Metraipolis › archive › dc_e3f2d2d2ec98
Targeted Ruthenium-Based Anti-Inflammatory Nanoagent for Enhanced Rheumatoid Arthritis Treatment — Europe PMC PMID:41163798
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41163798
- DOI
- 10.1002/exp.20240043
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T13:50:02.135Z
- SHA-256 of the archived text
768a9890c83fbd6ff48df72c00a205229d8f625ed573f0e1d8abe610452c87e3- Stable URL of this page
https://metraipolis.com/documento/dc_e3f2d2d2ec98
How to cite
Targeted Ruthenium-Based Anti-Inflammatory Nanoagent for Enhanced Rheumatoid Arthritis Treatment — Europe PMC PMID:41163798 — Europe PMC (en), https://europepmc.org/article/MED/41163798 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e3f2d2d2ec98 (Metraipolis archive dc_e3f2d2d2ec98, sha256 768a9890c83fbd6ff48df72c00a205229d8f625ed573f0e1d8abe610452c87e3)
BibTeX
@misc{dce3f2d2d2ec98,
title = {Targeted Ruthenium-Based Anti-Inflammatory Nanoagent for Enhanced Rheumatoid Arthritis Treatment — Europe PMC PMID:41163798},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41163798},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e3f2d2d2ec98; sha256 768a9890c83fbd6ff48df72c00a205229d8f625ed573f0e1d8abe610452c87e3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41163798. Agents can read the archived copy with the MCP tool read_document.